Construction of a eukaryotic expression system of HSP65 gene from Mycobacterium tuberculosis, and anti-HSP65 IgG produced in mice

References

1. Bloom B. R., Murray C. J. L. 1992; Tuberculosis: commentary on a reemergent killer. Science 257:1055–1064 [CrossRef]
   [Google Scholar]
2. Boyle J. S., Brady J. L., Lew A. M. 1998; Enhanced responses to a DNA vaccine encoding a fusion antigen that is directed to sites of immune induction. Nature 392:408–411 [CrossRef]
   [Google Scholar]
3. Chen K., Lu J., Wang L., Gan Y. H. 2004; Mycobacterial heat shock protein 65 enhances antigen cross-presentation in dendritic cells independent of Toll-like receptor 4 signaling. J Leukoc Biol 75:260–266
   [Google Scholar]
4. Colditz G. A., Brewer T. F., Berkey C. S., Wilson M. E., Burdik E., Fineburg H. V., Mosteller F. 1994; Efficacy of BCG vaccine in the prevention of tuberculosis.Meta-analysis of the published literature. JAMA 271:698–702 [CrossRef]
   [Google Scholar]
5. Johnston S. A., Barry M. A. 1997; Genetic to genomic vaccination. Vaccine 15:808–809 [CrossRef]
   [Google Scholar]
6. Lamb D. J., Ferns G. A. 2002; The magnitude of the immune response to heat shock protein-65 following BCG immunisation is associated with the extent of experimental atherosclerosis. Atherosclerosis 165:231–240 [CrossRef]
   [Google Scholar]
7. Lowrie D. B., Silva C. L. 2000; Enhancement of immunocompetence in tuberculosis by DNA vaccination. Vaccine 18:1712–1716 [CrossRef]
   [Google Scholar]
8. Quintana F. J., Carmi P., Cohen I. R. 2002; DNA vaccination with heat shock protein 60 inhibits cyclophosphamide-accelerated diabetes. J Immunol 169:6030–6035 [CrossRef]
   [Google Scholar]
9. Sambrook J., Fritsch E. F., Maniatis T. 1989 Molecular Cloning: a Laboratory Manual , 2nd edn. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory;
   [Google Scholar]
10. Schaaf H. S., Botha P., Beyers N., Gie R. P., Vermeulen H. A., Groenwald P., Coetzee G. J., Donald P. R. 1996; The 5-year outcome of multidrug resistant tuberculosis patients in the Cape Province of South Africa. Trop Med Int Health 1:718–722
    [Google Scholar]
11. Silva C. L. 1999; The potential use of heat-shock proteins to vaccinate against mycobacterial infections. Microbes Infect 1:429–435 [CrossRef]
    [Google Scholar]
12. Silva C. L., Pietro R. L., Januario A., Bonato V. L., Lima V. M., da Silva M. F., Lowrie D. B. 1995; Protection against tuberculosis by bone marrow cells expressing mycobacterial hsp65. Immunology 86:519–524
    [Google Scholar]
13. Silva C. L., Bonato V. L., Lima A. K. M., Coelho-Castelo A. A., Faccioli L. H., Sartori A., De Souza A. O., Leao S. C. 2001; Cytotoxic T cells and mycobacteria. FEMS Microbiol Lett 197:11–18 [CrossRef]
    [Google Scholar]
14. Tascon R. E., Colston M. J., Ragno S., Stavropoulos E., Gregory D., Lowrie D. B. 1996; Vaccination against tuberculosis by DNA injection. Nat Med 2:888–892 [CrossRef]
    [Google Scholar]